Profile data is unavailable for this security.
About the company
NovelStem International Corp. is a development-stage biotechnology holding company focused on stem cell-based technology. The Company's primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. Its NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. NetCo is a media business interest which owns Net Force, a book publishing franchise.
- Revenue in USD (TTM)15.00k
- Net income in USD-4.22m
- Incorporated1993
- Employees15.00
- LocationNovelstem International Corp2255 Glades Rd, Ste 237 WBOCA RATON 33431United StatesUSA
- Phone+1 (561) 998-8000
- Fax+1 (561) 998-2974
- Websitehttps://www.novelstem.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cbdMD Inc | 21.58m | -25.65m | 2.57m | 52.00 | -- | 0.6561 | -- | 0.119 | -19.96 | -19.96 | 9.27 | 1.01 | 0.8949 | 2.09 | 21.27 | 415,039.60 | -89.78 | -38.59 | -118.26 | -41.50 | 62.70 | 63.80 | -100.33 | -87.98 | 0.6107 | -3.01 | 0.4668 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| DSwiss Inc | 1.68m | 144.71k | 2.59m | 11.00 | 17.86 | 11.01 | 13.22 | 1.54 | 0.0007 | 0.0007 | 0.0081 | 0.0011 | 4.43 | 189.17 | 35.95 | 152,321.80 | 38.27 | -8.69 | 79.40 | -45.47 | 32.65 | 25.55 | 8.64 | -2.47 | 2.04 | 66.93 | 0.1198 | -- | -20.50 | 46.20 | -688.36 | -- | -66.17 | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.62m | 40.00 | -- | -- | -- | 0.9473 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| Axim Biotechnologies Inc | 85.35k | -5.59m | 2.62m | 6.00 | -- | -- | -- | 30.73 | -0.0249 | -0.0249 | 0.0003 | -0.0268 | 0.0214 | -- | -- | 14,225.00 | -140.13 | -154.34 | -- | -390.73 | -- | -- | -6,548.75 | -36,362.71 | -- | -1.16 | -- | -- | 345.05 | -27.38 | -29.10 | -- | -- | -- |
| Eloxx Pharmaceuticals Inc | 0.00 | -20.48m | 2.67m | 18.00 | -- | -- | -- | -- | -9.06 | -9.06 | 0.00 | -6.53 | 0.00 | -- | -- | 0.00 | -124.43 | -115.27 | -- | -155.33 | -- | -- | -- | -- | -- | -16.69 | -- | -- | -- | -- | 45.95 | -- | -22.56 | -- |
| Aridis Pharmaceuticals Inc | 22.36m | -1.14m | 2.79m | 37.00 | -- | -- | -- | 0.1246 | -0.1845 | -0.1845 | 0.7074 | -0.2648 | 2.40 | -- | 58.45 | 604,297.30 | -12.24 | -120.16 | -- | -678.29 | -- | -- | -5.11 | -1,559.63 | -- | -- | -- | -- | 101.37 | 29.16 | 34.43 | -- | -34.84 | -- |
| Virax Biolabs Group Ltd | 0.00 | -1.71m | 2.79m | 5.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.8568 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.0223 | -112.29 | -- | -- | -100.00 | -- | -162.50 | -- | -- | -- |
| Novelstem International Corp | 15.00k | -4.22m | 2.82m | 15.00 | -- | -- | -- | 187.84 | -0.09 | -0.09 | 0.0003 | -0.0478 | 0.0065 | -- | 10.00 | -- | -172.16 | -- | -1,011.77 | -- | -- | -- | -26,418.53 | -- | -- | -8.40 | 2.34 | -- | 0.00 | -- | -446.84 | -- | -- | -- |
| Aptevo Therapeutics Inc | 0.00 | -27.31m | 2.91m | 40.00 | -- | 0.0786 | -- | -- | -98.49 | -97.90 | 0.00 | 9.06 | 0.00 | -- | -- | 0.00 | -103.85 | -47.16 | -134.86 | -85.03 | -- | -- | -- | -583.47 | -- | -- | 0.00 | -- | -100.00 | -- | -365.90 | -- | -- | -- |
| AgriFORCE Growing Systems Ltd | 16.28k | -13.34m | 2.93m | 7.00 | -- | 0.2838 | -- | 179.76 | -10.78 | -10.78 | 0.0039 | 0.396 | 0.0009 | -- | 0.443 | 2,325.71 | -74.39 | -78.95 | -100.77 | -109.86 | 16.58 | -- | -81,946.25 | -243,182.50 | 0.8186 | -1.30 | 0.1913 | -- | -- | -- | 8.85 | -- | 48.61 | -- |
| Biostax Corp | 0.00 | -1.57m | 2.93m | -- | -- | -- | -- | -- | -0.0188 | -0.0188 | 0.00 | -0.058 | 0.00 | -- | -- | -- | -390.77 | -81.51 | -- | -- | -- | -- | -- | -- | -- | -6.05 | -- | -- | -- | -- | 53.32 | -- | -- | -- |
| Veritas Farms Inc | 730.65k | -6.15m | 2.93m | 17.00 | -- | 14.49 | -- | 4.01 | -0.1319 | -0.1319 | 0.0136 | 0.0013 | 0.0877 | 0.8064 | 7.80 | 42,979.41 | -69.02 | -72.11 | -123.21 | -93.59 | -220.09 | 24.07 | -787.27 | -177.79 | 0.1392 | -5.56 | 0.95 | -- | -63.42 | -0.9427 | 23.68 | -- | -52.93 | -- |
| ENDRA Life Sciences Inc | 0.00 | -9.89m | 2.97m | 21.00 | -- | 0.7939 | -- | -- | -1.26 | -1.26 | 0.00 | 0.3388 | 0.00 | -- | -- | 0.00 | -168.89 | -132.00 | -228.29 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
| Mosaic Immunoengineering Inc | 0.00 | -897.69k | 3.04m | 3.00 | -- | -- | -- | -- | -0.1245 | -0.1245 | 0.00 | -0.8498 | 0.00 | -- | -- | 0.00 | -789.46 | -- | -- | -- | -- | -- | -- | -- | -- | -26.91 | -- | -- | -- | -- | 57.65 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| FNY Capital Management LPas of 31 Mar 2024 | 25.00k | 0.05% |
